We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Detection of Bone Marrow Changes: Comparison of MRI and DECT

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01211392
First Posted: September 29, 2010
Last Update Posted: March 30, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Gustav Andreisek, University of Zurich
  Purpose
Prospective study where magnetic resonance imaging is compared to dual-energy computed tomography for the detection of bone marrow changes.

Condition Intervention Phase
Bone Marrow Changes Other: magnetic resonance imaging Phase 1

Study Type: Observational
Study Design: Time Perspective: Prospective

Resource links provided by NLM:


Further study details as provided by Gustav Andreisek, University of Zurich:

Enrollment: 40
Study Start Date: October 2010
Primary Completion Date: January 2016 (Final data collection date for primary outcome measure)
Intervention Details:
    Other: magnetic resonance imaging
    magnetic resonance imaging is compared to dual-energy computed tomography for the detection of bone marrow changes
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 90 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients with bone marrow changes
Criteria

Inclusion criteria:

  • Patients with bone marrow changes

Exclusion criteria:

  • Pregnacy
  • Age below 18 ys old
  • Contraindications for MRI
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01211392


Locations
Switzerland
Zurich, Switzerland
Sponsors and Collaborators
University of Zurich
Investigators
Study Director: 01 Studienregister MasterAdmins UniversitaetsSpital Zuerich
  More Information

Responsible Party: Gustav Andreisek, MD, University of Zurich
ClinicalTrials.gov Identifier: NCT01211392     History of Changes
Other Study ID Numbers: 005
First Submitted: September 28, 2010
First Posted: September 29, 2010
Last Update Posted: March 30, 2016
Last Verified: March 2016